Cao Shu Zhen - Net Worth and Insider Trading
Cao Shu Zhen Net Worth
The estimated net worth of Cao Shu Zhen is at least $12 Million dollars as of 2024-11-08. Cao Shu Zhen is the senior management of Tibet Rhodiola Pharmaceutical Holding Co and owns about 300,300 shares of Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) stock worth over $12 Million. Details can be seen in Cao Shu Zhen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Cao Shu Zhen has not made any transactions after 2008-01-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Cao Shu Zhen
Cao Shu Zhen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Cao Shu Zhen owns 1 companies in total, including Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) .
Click here to see the complete history of Cao Shu Zhen’s form 4 insider trades.
Insider Ownership Summary of Cao Shu Zhen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:600211 | Tibet Rhodiola Pharmaceutical Holding Co | 2008-01-25 | senior management |
Cao Shu Zhen Latest Holdings Summary
Cao Shu Zhen currently owns a total of 1 stock. Cao Shu Zhen owns 300,300 shares of Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) as of January 25, 2008, with a value of $12 Million.
Latest Holdings of Cao Shu Zhen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:600211 | Tibet Rhodiola Pharmaceutical Holding Co | 2008-01-25 | 300,300 | 40.14 | 12,054,042 |
Holding Weightings of Cao Shu Zhen
Cao Shu Zhen Form 4 Trading Tracker
According to the SEC Form 4 filings, Cao Shu Zhen has made a total of 0 transactions in Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) over the past 5 years. The most-recent trade in Tibet Rhodiola Pharmaceutical Holding Co is the sale of 300,300 shares on January 25, 2008, which brought Cao Shu Zhen around $835,800.
Insider Trading History of Cao Shu Zhen
- 1
Cao Shu Zhen Trading Performance
GuruFocus tracks the stock performance after each of Cao Shu Zhen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Cao Shu Zhen is -40%. GuruFocus also compares Cao Shu Zhen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Cao Shu Zhen within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Cao Shu Zhen's insider trading performs compared to the benchmark.
Performance of Cao Shu Zhen
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.85 | | | | | |
| Relative Return to S&P 500(%) | 2.75 | | | | | |
Cao Shu Zhen Ownership Network
Ownership Network List of Cao Shu Zhen
Ownership Network Relation of Cao Shu Zhen
Cao Shu Zhen Owned Company Details
What does Tibet Rhodiola Pharmaceutical Holding Co do?
Who are the key executives at Tibet Rhodiola Pharmaceutical Holding Co?
Cao Shu Zhen is the senior management of Tibet Rhodiola Pharmaceutical Holding Co. Other key executives at Tibet Rhodiola Pharmaceutical Holding Co include senior management Wang Bao Ming , Supervisors Ren Bei Chen , and Supervisors Liu De Gong .
Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tibet Rhodiola Pharmaceutical Holding Co Insider Transactions
Cao Shu Zhen Mailing Address
Above is the net worth, insider trading, and ownership report for Cao Shu Zhen. Currently GuruFocus does not have mailing address information for Cao Shu Zhen.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
